The use of anticoagulants in patients with non-valvular atrial fibrillation between 2005 and 2014: A drug utilization study using claims data in Japan - Fig 3

The prevalence of non-valvular atrial fibrillation (per/100,000 persons) age- and gender-standardized to Japanese population aged 20–74 years at the 2012 census (a) and the proportion of the prevalence subdivided by the use of the drug for stroke prevention (b) between the first quarter (Q1) of 2005 and the first quarter of 2014. DOAC: direct oral anticoagulant.